To further explore the molecular mechanisms underlying the tumor‐suppressive effects of METTL3 in hepatocarcinogenesis, we conducted RNA‐sequencing on liver tissues from two groups of mice 3 weeks post‐HTVI (four individuals per group) (Fig. S5A). This evidence concerns the gene METTL3 and neoplasm.